{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T15:40:51Z","timestamp":1768491651391,"version":"3.49.0"},"posted":{"date-parts":[[2020,8,10]]},"group-title":"Microbiology","reference-count":52,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2020,8,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>The raging COVID-19 pandemic caused by SARS-CoV2 has infected millions of people and killed several hundred thousand patients worldwide. Currently, there are no effective drugs or vaccines available for treating coronavirus infections. In this study, we have focused on the SARS-CoV2 helicase (Nsp13), which is critical for viral replication and the most conserved non-structural protein within the coronavirus family. Using homology modeling and molecular dynamics approaches, we generated structural models of the SARS-CoV2 helicase in its apo- and ATP\/RNA-bound conformations. We performed virtual screening of ~970,000 chemical compounds against the ATP binding site to identify potential inhibitors. Herein, we report docking hits of approved human drugs targeting the ATP binding site. Importantly, two of our top drug hits have significant activity in inhibiting purified recombinant SARS-CoV-2 helicase, providing hope that these drugs can be potentially repurposed for the treatment of COVID-19.<\/jats:p>","DOI":"10.1101\/2020.08.09.243246","type":"posted-content","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T03:15:13Z","timestamp":1597115713000},"source":"Crossref","is-referenced-by-count":12,"title":["Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase"],"prefix":"10.64898","author":[{"given":"Mark Andrew","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-1694","authenticated-orcid":false,"given":"Xiaodong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024080410450870000_2020.08.09.243246v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30154-9"},{"key":"2024080410450870000_2020.08.09.243246v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)302518"},{"key":"2024080410450870000_2020.08.09.243246v1.3","doi-asserted-by":"publisher","DOI":"10.1126\/science.1085953"},{"key":"2024080410450870000_2020.08.09.243246v1.4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-020518-115759"},{"key":"2024080410450870000_2020.08.09.243246v1.5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00957-12"},{"key":"2024080410450870000_2020.08.09.243246v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.04.081"},{"key":"2024080410450870000_2020.08.09.243246v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2014.06.002"},{"key":"2024080410450870000_2020.08.09.243246v1.8","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz409"},{"key":"2024080410450870000_2020.08.09.243246v1.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006474"},{"issue":"1","key":"2024080410450870000_2020.08.09.243246v1.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbabio.2004.06.003","article-title":"RecA-like Motor ATPases\u2014Lessons from Structures","volume":"1659","year":"2004","journal-title":"Biochimica et Biophysica Acta (BBA) - Bioenergetics"},{"key":"2024080410450870000_2020.08.09.243246v1.11","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444910007493"},{"key":"2024080410450870000_2020.08.09.243246v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2011.07.005"},{"key":"2024080410450870000_2020.08.09.243246v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2011.02.010"},{"key":"2024080410450870000_2020.08.09.243246v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2005.12.051"},{"key":"2024080410450870000_2020.08.09.243246v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152956"},{"key":"2024080410450870000_2020.08.09.243246v1.16","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198122060-00002"},{"issue":"4","key":"2024080410450870000_2020.08.09.243246v1.17","first-page":"234","article-title":"TREATMENT OF MIGRAINE-Results with Dihydroergocornine Methanesulfonate (DHO-180) and Other Ergot Derivatives","volume":"72","year":"1950","journal-title":"Calif Med"},{"key":"2024080410450870000_2020.08.09.243246v1.18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.2.221"},{"key":"2024080410450870000_2020.08.09.243246v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/srep16541"},{"issue":"6","key":"2024080410450870000_2020.08.09.243246v1.20","first-page":"664","article-title":"The Use of Ergotamine Tartrate in Migraine","volume":"33","year":"1935","journal-title":"Can Med Assoc J"},{"issue":"4","key":"2024080410450870000_2020.08.09.243246v1.21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/jcph.1338","article-title":"Complementary Pharmacokinetic Profiles of Netupitant and Palonosetron Support the Rationale for Their Oral Fixed Combination for the Prevention of Chemotherapy-Induced Nausea and Vomiting","volume":"59","year":"2019","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"2024080410450870000_2020.08.09.243246v1.22","first-page":"395","article-title":"Corneal Inflammation Is Inhibited by the LFA-1 Antagonist, Lifitegrast (SAR 1118)","volume":"29","year":"2013","journal-title":"JOculPharmacol Ther"},{"issue":"10","key":"2024080410450870000_2020.08.09.243246v1.23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1358\/dot.2007.43.10.1122218","article-title":"Nilotinib Therapy in Chronic Myelogenous Leukemia","volume":"43","year":"2007","journal-title":"Drugs Today"},{"issue":"1","key":"2024080410450870000_2020.08.09.243246v1.24","doi-asserted-by":"crossref","first-page":"e0210182","DOI":"10.1371\/journal.pone.0210182","article-title":"Curare Alkaloids from Matis Dart Poison: Comparison with d-Tubocurarine in Interactions with Nicotinic, 5-HT3 Serotonin and GABAA Receptors","volume":"14","year":"2019","journal-title":"PLoS ONE"},{"issue":"7","key":"2024080410450870000_2020.08.09.243246v1.25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-2600(14)70132-8","article-title":"A CFTR Corrector (Lumacaftor) and a CFTR Potentiator (Ivacaftor) for Treatment of Patients with Cystic Fibrosis Who Have a Phe508del CFTR Mutation: A Phase 2 Randomised Controlled Trial","volume":"2","author":"VX09-809-102 study group","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024080410450870000_2020.08.09.243246v1.26","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464070-00013"},{"issue":"4","key":"2024080410450870000_2020.08.09.243246v1.27","first-page":"606","article-title":"Irinotecan. A Review of Its Pharmacological Properties and Clinical Efficacy in the Management of Advanced Colorectal Cancer","volume":"52","year":"1996","journal-title":"Drugs"},{"issue":"I","key":"2024080410450870000_2020.08.09.243246v1.28","first-page":"78","article-title":"Synthetic Conjugated Estrogens-B and Postmenopausal Nocturnal Vasomotor Symptoms: A Randomized Controlled Trial","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2024080410450870000_2020.08.09.243246v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3579"},{"key":"2024080410450870000_2020.08.09.243246v1.30","unstructured":"Minutello, K. ; Gupta, V. Cromolyn Sodium. In StatPearls; StatPearls Publishing: Treasure Island (FL), 2020."},{"issue":"1","key":"2024080410450870000_2020.08.09.243246v1.31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF01966674","article-title":"The Effects of Diosmin (a Benzo-Pyrone) upon Some High-Protein Oedemas: Lung Contusion, and Burn and Lymphoedema of Rat Legs","volume":"17","year":"1985","journal-title":"Agents Actions"},{"key":"2024080410450870000_2020.08.09.243246v1.32","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199201001-00049"},{"issue":"1","key":"2024080410450870000_2020.08.09.243246v1.33","first-page":"61","article-title":"Adapalene, a New Chemical Entity with Retinoid Activity","volume":"6","year":"1993","journal-title":"Skin Pharmacol."},{"key":"2024080410450870000_2020.08.09.243246v1.34","unstructured":"Clinical Review Report: Lumacaftor\/Ivacaftor (Orkambi): (Vertex Pharmaceuticals (Canada) Incorporated): Indication: For the Treatment of Cystic Fibrosis in Patients Aged Six Years and Older Who Are Homozygous for the F508del Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Gene; CADTH Common Drug Reviews; Canadian Agency for Drugs and Technologies in Health: Ottawa (ON), 2018."},{"key":"2024080410450870000_2020.08.09.243246v1.35","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5486.1938"},{"key":"2024080410450870000_2020.08.09.243246v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.01.007"},{"key":"2024080410450870000_2020.08.09.243246v1.37","doi-asserted-by":"crossref","unstructured":"Ruan, Z. ; Liu, C. ; Guo, Y ; He, Z. ; Huang, X. ; Jia, X. ; Yang, T. SARS-CoV-2 and SARS-CoV: Virtual Screening of Potential Inhibitors Targeting RNA-Dependent RNA Polymerase Activity (NSP12). J. Med. Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.26222.","DOI":"10.20944\/preprints202003.0024.v1"},{"key":"2024080410450870000_2020.08.09.243246v1.38","doi-asserted-by":"crossref","unstructured":"Rogosnitzky, M. ; Okediji, P. ; Koman, I. Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19. Pharmacol Rep 2020. https:\/\/doi.org\/10.1007\/s43440-020-00132-z.","DOI":"10.31219\/osf.io\/5e9gk"},{"issue":"6","key":"2024080410450870000_2020.08.09.243246v1.39","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1096\/fj.202000654R","article-title":"The Lysosome: A Potential Juncture between SARS-CoV-2 Infectivity and Niemann-Pick Disease Type C, with Therapeutic Implications","volume":"34","year":"2020","journal-title":"FASEB J."},{"issue":"6","key":"2024080410450870000_2020.08.09.243246v1.40","first-page":"493","article-title":"Antiviral Activity of Cepharanthine against Severe Acute Respiratory Syndrome Coronavirus in Vitro","volume":"118","year":"2005","journal-title":"Chin. Med. J."},{"key":"2024080410450870000_2020.08.09.243246v1.41","doi-asserted-by":"crossref","unstructured":"Riva, L. ; Yuan, S. ; Yin, X. ; Martin-Sancho, L. ; Matsunaga, N. ; Pache, L. ; Burgstaller-Muehlbacher, S. ; De Jesus, P. D. ; Teriete, P. ; Hull, M. V. ; Chang, M. W. ; Chan, J. F.-W. ; Cao, J. ; Poon, V K.-M. ; Herbert, K. M. ; Cheng, K. ; Nguyen, T.-T. H. ; Rubanov, A. ; Pu, Y ; Nguyen, C. ; Choi, A. ; Rathnasinghe, R. ; Schotsaert, M. ; Miorin, L. ; Dejosez, M. ; Zwaka, T. P. ; Sit, K.-Y ; Martinez-Sobrido, L. ; Liu, W.-C. ; White, K. M. ; Chapman, M. E. ; Lendy, E. K. ; Glynne, R. J. ; Albrecht, R. ; Ruppin, E. ; Mesecar, A. D. ; Johnson, J. R. ; Benner, C. ; Sun, R. ; Schultz, P. G. ; Su, A. I. ; Garc\u00eda-Sastre, A. ; Chatterjee, A. K. ; Yuen, K.-Y ; Chanda, S. K. Discovery of SARS-CoV-2 Antiviral Drugs through Large-Scale Compound Repurposing. Nature 2020. https:\/\/doi.org\/10.1038\/s41586-020-2577-1.","DOI":"10.1038\/s41586-020-2577-1"},{"issue":"9","key":"2024080410450870000_2020.08.09.243246v1.42","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","article-title":"Repurposing of Clinically Approved Drugs for Treatment of Coronavirus Disease 2019 in a 2019-Novel Coronavirus-Related Coronavirus Model","volume":"133","year":"2020","journal-title":"Chin. Med. J."},{"key":"2024080410450870000_2020.08.09.243246v1.43","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20289"},{"key":"2024080410450870000_2020.08.09.243246v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/0263-7855(96)00018-5"},{"key":"2024080410450870000_2020.08.09.243246v1.45","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"issue":"10","key":"2024080410450870000_2020.08.09.243246v1.46","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1021\/ci500531r","article-title":"Identification of a Novel Inhibitor of Dengue Virus Protease through Use of a Virtual Screening Drug Discovery Web Portal","volume":"54","year":"2014","journal-title":"J Chem Inf Model"},{"key":"2024080410450870000_2020.08.09.243246v1.47","doi-asserted-by":"publisher","DOI":"10.1021\/ci3001277"},{"key":"2024080410450870000_2020.08.09.243246v1.48","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5b00559"},{"issue":"8","key":"2024080410450870000_2020.08.09.243246v1.49","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/bioinformatics\/btz976","article-title":"ChemBioServer 2.0: An Advanced Web Server for Filtering, Clustering and Networking of Chemical Compounds Facilitating Both Drug Discovery and Repurposing","volume":"36","year":"2020","journal-title":"Bioinformatics"},{"key":"2024080410450870000_2020.08.09.243246v1.50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C300328200"},{"key":"2024080410450870000_2020.08.09.243246v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(86)90640-8"},{"key":"2024080410450870000_2020.08.09.243246v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(88)90290-4"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2020.08.09.243246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:43:10Z","timestamp":1768437790000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2020.08.09.243246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":52,"URL":"https:\/\/doi.org\/10.1101\/2020.08.09.243246","relation":{},"subject":[],"published":{"date-parts":[[2020,8,10]]},"subtype":"preprint"}}